Latest Neurotrauma Stories

Constraint Therapy Australia offers a new intensive rehabilitation program to help people who have suffered a stroke as well as those with cerebral palsy and some other neurological conditions. Perth, Australia (PRWEB) June 18, 2013 A ground-breaking therapy service has been launched in Perth to offer stroke patients a new rehabilitation treatment. Constraint Therapy Australia celebrated its launch earlier this month and offers a new intensive rehabilitation program to help people who...

Scientists are scrambling to gather data for the FDA to support the need for a blood test to diagnose brain injury in the United States. The University of Rochester Medical Center just added significant evidence by reporting in the Journal of Neurotrauma that it might be clinically useful to measure two brain biomarkers instead of one. Jeffrey J. Bazarian, M.D., M.P.H., an associate professor of Emergency Medicine at URMC, believes he's the first to show that measuring a combination of two...

The distribution of white matter brain abnormalities in some patients after mild traumatic brain injury (MTBI) closely resembles that found in early Alzheimer's dementia, according to a new study published online in the journal Radiology. "Findings of MTBI bear a striking resemblance to those seen in early Alzheimer's dementia," said the study's lead author, Saeed Fakhran, M.D., assistant professor of radiology in the Division of Neuroradiology at the University of Pittsburgh School of...

The distribution of white matter brain abnormalities in some patients after mild traumatic brain injury (MTBI) closely resembles that found in early Alzheimer’s dementia, according to a new study published online, June 18, in the journal Radiology. Oak Brook, IL (PRWEB) June 17, 2013 The distribution of white matter brain abnormalities in some patients after mild traumatic brain injury (MTBI) closely resembles that found in early Alzheimer’s dementia, according to a new study...

Intrepid Spirit III is Third of Nine Planned Centers Nationwide; Will Serve Military Heroes at Fort Campbell, KY FORT CAMPBELL, Ky., June 13, 2013 /PRNewswire-USNewswire/ -- Military leaders, including Gen. Robert Cone, Commanding General for the United States Army Training and Doctrine Command, and Brig. Gen. Mark Stammer, 101(st) Airborne Division (Air Assault) and Fort Campbell Senior Mission Commander, joined leaders of the Intrepid Fallen Heroes Fund (IFHF) at a groundbreaking...

Soccer players who 'head' the ball with high frequency demonstrate poorer performance on memory tests and have brain abnormalities similar to those found in traumatic brain injury patients, according to a study published online in the journal Radiology. "We chose to study soccer players, because soccer is the most popular sport worldwide," said Michael L. Lipton, M.D., Ph.D., associate director of the Gruss Magnetic Resonance Research Center at the Albert Einstein College of Medicine and...

New resource provided for consumers who have been inquiring about information involving legal rights over allegations of medical malpractice and birth injuries. Site also offers links to free consultations in such cases. San Diego, CA (PRWEB) June 10, 2013 http://www.resource4thepeople.com/medicalmalpractice/cerebralpalsy-lawsuit.html Resource4thePeople announced today that it has launched a new medical malpractice/cerebral palsy information bank for consumers who have claims involving...

Soccer players who ‘head’ the ball with high frequency demonstrate poorer performance on memory tests and have brain abnormalities similar to those found in traumatic brain injury patients, according to a study published online, June 11, in the journal Radiology. Oak Brook, IL (PRWEB) June 10, 2013 Soccer players who ‘head’ the ball with high frequency demonstrate poorer performance on memory tests and have brain abnormalities similar to those found in traumatic brain injury...

MOUNTAIN VIEW, Calif., June 10, 2013 /PRNewswire/ -- SanBio Inc., a California-based regenerative medicine company, announced today that the U.S. Food and Drug Administration has approved their Investigational New Drug application (IND) for the use of SB623, a novel allogeneic stem cell therapy product, in patients suffering from traumatic brain injuries (TBI's). This approval allows the company to proceed with a Phase 1/2a clinical trial testing the safety and feasibility of the...

Will Present Final ALS Phase I Results Including New Cervical Cohort Data ROCKVILLE, Md., June 10, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported that Eva Feldman, MD, PhD, will address the Canadian Neurological Sciences Federation Annual Congress, in Montreal, Canada, on Thursday, June 13(th) at 8:30 a.m. ET as a grand plenary speaker (http://congress.cnsfederation.org/). Dr. Feldman will present final data from Neuralstem's Phase I trial testing NSI-566 spinal...